Breaking News
March 23, 2019 - Lung cancer survivor recounts her lifetime struggles
March 23, 2019 - Radial and femoral approach for PCI achieve similar results in terms of survival
March 23, 2019 - Study sheds light on the optimal timing of coronary angiography in NSTEMI patients
March 23, 2019 - Excess hormones could cause a condition that can lead to blindness in women, study finds
March 23, 2019 - Dramatic shifts in first-time opioid prescriptions bring hope, concern
March 23, 2019 - Antidepressant drugs may not work when neurons are out of shape
March 23, 2019 - TTUHSC El Paso to establish endowed chair in neurology through a major grant
March 23, 2019 - New device approved by FDA for treating patients with moderate-to-severe heart failure
March 23, 2019 - People with peripheral artery disease have lower Omega-3 Index, shows research
March 23, 2019 - Trigger warnings have minimal impact on how people respond to content, shows research
March 23, 2019 - Gilead Announces Data From Two Studies Supporting Further Development of GS-6207, a Novel, Investigational HIV-1 Capsid Inhibitor as a Component of Future Long-Acting HIV Therapies
March 23, 2019 - Selfish genetic elements amplify inflammation and age-related diseases
March 23, 2019 - Study provides new understanding of how the brain recovers from damage caused by stroke
March 23, 2019 - CRISPR/Cas libraries could revolutionize drug discovery
March 23, 2019 - Allergic reaction during pregnancy may alter sexual-development in offspring’s brain
March 23, 2019 - Seeing through a robot’s eyes helps those with profound motor impairments
March 23, 2019 - Recent research shows that ease of breastfeeding after C-section differs culturally
March 23, 2019 - Newly discovered parameters offer more control over efficient release of drugs
March 23, 2019 - ‘De-tabooing’ of abortion- Women would like more support from health care community
March 23, 2019 - Anti-TB drugs can increase susceptibility to Mtb reinfection
March 23, 2019 - New survey indicates need of attention to neglected tropical diseases
March 23, 2019 - Innovative in vitro method to develop easy-to-swallow medicine for children and older people
March 23, 2019 - Sugary drinks could raise risk of early deaths finds study
March 23, 2019 - Lian wins ENGINE grant for stem-cell-based therapy to treat Type 1 diabetes
March 23, 2019 - Overall, Physicians Are Happy and Enjoy Their Lives
March 23, 2019 - Researchers discover how blood vessels protect the brain during inflammation
March 23, 2019 - CDC study shows modest improvement in optimal hospital breastfeeding policy
March 23, 2019 - Family-based prevention program to reduce alcohol use among older teens
March 23, 2019 - Remote monitoring of implanted defibrillators in heart failure patients prevents hospitalizations
March 23, 2019 - Appropriate doffing of personal protective equipment may reduce healthcare worker contamination
March 23, 2019 - Window screens can suppress mosquito populations, reduce malaria in Tanzania
March 23, 2019 - Researchers discover new biomarker for postoperative liver dysfunction
March 23, 2019 - Pregnancy history may be linked to cognitive function in older women, finds study
March 23, 2019 - Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack
March 23, 2019 - FDA Approves First Drug for Postpartum Depression, Zulresso (brexanolone)
March 23, 2019 - New guidelines outline new treatment management for psoriasis
March 23, 2019 - Thermally abused cooking oil may promote progression of breast cancer
March 23, 2019 - High-fructose corn syrup fuels growth of colon tumors in mice
March 23, 2019 - Partnership aims at establishing best practices to promote diversity in clinical trials
March 23, 2019 - New study examines presence of microbes in tap water from residences, office buildings
March 23, 2019 - Early life trauma may affect brain structure, contribute to major depressive disorder
March 23, 2019 - NIH starts clinical trial of drug to treat cravings associated with opioid use disorder
March 23, 2019 - Cervix bacteria, immune factors could be a warning signal of premature birth, reports new research
March 23, 2019 - Worst-ever emergency care performance figures underscore the need to focus on staffing
March 23, 2019 - The Current issue of “The view from here” is concerned with Cancer
March 23, 2019 - Mouse model validates how ‘good’ and ‘bad’ bacteria affect acne
March 23, 2019 - Individual amygdala neurons respond to touch, imagery and sounds
March 23, 2019 - Combination of two topical creams can prevent cancer
March 23, 2019 - Study suggests depression screening when assessing African-Americans for schizophrenia
March 23, 2019 - New electronic support system for choosing drug treatment based on patient’s genotype
March 23, 2019 - First-of-its-kind study provides pregnancy statistics of imprisoned U.S. women
March 23, 2019 - Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy
March 23, 2019 - Laparoscopy: MedlinePlus Lab Test Information
March 23, 2019 - Shellfish allergies: can they be treated?
March 23, 2019 - Toilet seat heart monitoring system
March 23, 2019 - Researchers identify way to improve common treatment for PTSD
March 23, 2019 - High potency cannabis use linked to psychosis finds study
March 23, 2019 - Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA
March 23, 2019 - Tracking HIV’s ever-evolving genome in effort to prioritize public health resources
March 23, 2019 - Scientists grow most sophisticated brain organoid to date
March 23, 2019 - ADHD drug raising risk of psychosis
March 22, 2019 - FDA approves brexanolone, first drug developed to treat postpartum depression
March 22, 2019 - Gruesome cat and dog experiments by the USDA exposed
March 22, 2019 - Ball pits used in children’s physical therapy may contribute to germ transmission
March 22, 2019 - Long-term use of inexpensive weight-loss drug may be safe and effective
March 22, 2019 - FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
March 22, 2019 - Anti-Müllerian Hormone Test: MedlinePlus Lab Test Information
March 22, 2019 - Finding the right exercise, diet aids for HIV patients
March 22, 2019 - Health Plans For State Employees Use Medicare’s Hammer On Hospital Bills
March 22, 2019 - Researchers develop new tool for imaging large groups of neurons in living animals
March 22, 2019 - Certain bacteria and immune factors in vagina may cause or protect against preterm birth
March 22, 2019 - Research identifies guidelines for prioritizing hepatitis C treatment in U.S. prisons
March 22, 2019 - Novel breath test could pave new way to non-invasively measure gut health
March 22, 2019 - Pharmaceutical and personal care products may result in new contaminants in waterways
March 22, 2019 - New model could revolutionize the way researchers investigate spread of pathogens
March 22, 2019 - MSU professor receives NSF CAREER grant for biosensor diagnostics
March 22, 2019 - High-fat, high-sugar diet in mouse mothers causes problems in the hearts of offspring
March 22, 2019 - ACC: Catheter Ablation Does Not Cut Mortality, Stroke in A-Fib
March 22, 2019 - Wiedemann-Rautenstrauch syndrome – Genetics Home Reference
March 22, 2019 - Health insurance is not assurance of healthcare
Post-CABG Afib Associated with Minimal Stroke Risk

Post-CABG Afib Associated with Minimal Stroke Risk

image_pdfDownload PDFimage_print

Action Points

  • Note that this observational study found that the risk of stroke was lower among patients with atrial fibrillation that developed after CABG compared to those who developed atrial fibrillation via other mechanisms.
  • Be aware this raises the question of whether anticoagulation should even be initiated for atrial fibrillation after CABG — a large clinical trial may be needed.

New-onset atrial fibrillation after coronary artery bypass grafting (CABG) surgery was associated with a lower, long-term thromboembolic risk than seen with nonsurgical, nonvalvular AF (NVAF), an observational study found.

The risk of thromboembolism — ischemic stroke, transient cerebral ischemia, and thrombosis or embolism in peripheral arteries — was lower in the postoperative AF (POAF) group than in the NVAF group (18.3 versus 29.7 events per 1,000 person-years; adjusted HR 0.67, 95% CI 0.55-0.81, P<0.001), Jawad Butts, MD, of Rigshospitalet Copenhagen University Hospital, and colleagues reported online March 28 in JAMA Cardiology.

This lower risk was despite substantially lower initiation of oral anticoagulation therapy within 30 days post-discharge in POAF (8.4%) compared with NVAF (42.9%).

In fact, patients who developed POAF following CABG had a statistically similar risk for vessel obstruction due to blood clots as patients who remained in sinus rhythm (adjusted HR 1.11, 95% CI 0.94-1.32, P<0.24).

The study is among the first to examining the long-term risk of thromboembolism associated with POAF following CABG, which occurs in 11% to 40% of patients, according to the researchers.

“Our data do not support the notion that new-onset POAFs should be regarded as similar to primary NVAF in terms of long-term thromboembolic risk,” wrote

The researchers noted that while oral anticoagulation clearly reduces stroke and systemic embolism risk in patients with NVAF, “data on stroke prophylaxis in new-onset POAF after CABG are lacking, and international guidelines on the management of patients with AF do not provide clear recommendations on this issue.”

Anticoagulation therapy during follow-up was associated with a lower risk of thromboembolic events in both patients with POAF (adjusted HR, 0.55, 95% CI, 0.32-0.95; P=0.03) and NVAF (adjusted HR, 0.59, 95% CI, 0.51-0.68; P<0.001) compared with patients who did not receive any anticoagulation therapy.

However, “no causal inferences can be made from the analysis on the effectiveness of oral anticoagulation (OAC) therapy for the prevention of thromboembolism in the two cohorts, although these data suggest that therapy is associated with a similar lower thromboembolic risk among groups,” the researchers cautioned.

Butts and colleagues used data from a clinical cardiac surgery database and nationwide patient registries in Denmark to identify patients undergoing first-time CABG surgery who developed new-onset POAF during a 15-year period beginning in 2000.

Each of those patients was matched by age, sex, CHA2DS2-VASc score and year of diagnosis to four patients with nonsurgical NVAF. In all, 2,108 post CABG patients who developed POAF were matched with 8,432 patients with NVAF.

Study limitations included the possibility of residual confounding associated with the observational design.

The study is not the first to suggest that new-onset AF following cardiac surgery poses a lower risk for stroke than traditional AF. Separate research published in 2014 by Whitlock et al. and Gialdini et al. also showed a lower risk for blood clots and stroke in patients who developed POAF.

The findings “have important implications for how clinicians should treat patients with this common problem,” Jeff Healey, MD, of McMaster University, Ontario, Canada, and colleagues, wrote in an invited commentary published with the study.

“It is likely that some AF following cardiac surgery is indeed transient and caused by inflammation, while in other cases, it is typical clinical AF in an at-risk individual that happens to receive a diagnosis for the first time in the postoperative setting,” they wrote, adding that it is not yet possible to distinguish between the two groups.

They concluded that given the observed lower risk for stroke associated with POAF in the three cohort studies and the low rate of oral anticoagulant use in the post-CABG AF setting, “there is clinical equipoise regarding the need for long-term oral anticoagulation therapy in this setting.”

“A large clinical trial would be invaluable to help resolve this uncertainty. Until such time, clinicians must use their best judgment regarding the need for long-term anticoagulation therapy,” they wrote.

The researchers reported no funding source nor disclosures of conflict of interest within the scope of this study.

Healey disclosed research grants from Bristol-Myers Squibb and Pfizer.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2018-03-28T14:45:00-0400

Tagged with:

About author

Related Articles